Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of clinically useful cancer prognostic factors: what are we missing?

× No keyword cloud information.

35 in total

1. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors: Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal: BMC Med Date: 2012-05-29 Impact factor: 8.775

2. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors: Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal: PLoS Med Date: 2012-05-29 Impact factor: 11.069

3. [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors: T Decker; D Hungermann; W Böcker
Journal: Pathologe Date: 2009-02 Impact factor: 1.011

Review 4. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors: C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal: J Clin Pathol Date: 2006-08 Impact factor: 3.411

5. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

Authors: Shuji Ogino; Emily E King; Andrew H Beck; Mark E Sherman; Danny A Milner; Edward Giovannucci
Journal: Am J Epidemiol Date: 2012-08-30 Impact factor: 4.897

6. Cancer immunotherapy drives implementation science in oncology.

Authors: Daniel E Speiser; Lukas Flatz
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

Review 7. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.

Authors: S Mallett; A Timmer; W Sauerbrei; D G Altman
Journal: Br J Cancer Date: 2009-12-08 Impact factor: 7.640

8. Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma.

Authors: Nina Wagener; Stephan Macher-Goeppinger; Maria Pritsch; Johannes Hüsing; Karin Hoppe-Seyler; Peter Schirmacher; Jesco Pfitzenmaier; Axel Haferkamp; Felix Hoppe-Seyler; Markus Hohenfellner
Journal: BMC Cancer Date: 2010-10-04 Impact factor: 4.430

Review 9. Publication of tumor marker research results: the necessity for complete and transparent reporting.

Authors: Lisa M McShane; Daniel F Hayes
Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544

10. Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

Authors: Eiman Aleem; Ayman Elshayeb; Nihal Elhabachi; Amal Refaat Mansour; Ahmed Gowily; Asmaa Hela
Journal: Oncol Lett Date: 2011-12-30 Impact factor: 2.967